Evidence map›Paper›PMID 37138560›Full record

ArticleFrontiers in pediatrics2023

Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease.

Jesús Javier Martínez-García, Jesús Ramon López-Acosta, Daniela Arce-Cabrera, Nidia León-Sicairos, Ana Cristina Hernández-Parra, Hector Melesio Cuen-Diaz, Ricardo Zatarain-Lopez, Adrian Canizalez-Roman

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jesús Javier Martínez-GarcíaPediatric Intensive Care Unit, Pediatric Hospital of Sinaloa, Culiacan, Mexico.
Jesús Ramon López-AcostaPediatric Intensive Care Unit, Pediatric Hospital of Sinaloa, Culiacan, Mexico.
Daniela Arce-CabreraHematology and Oncology Unit, Pediatric Hospital of Sinaloa, Culiacan, Mexico.
Nidia León-SicairosSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Ana Cristina Hernández-ParraPediatric Intensive Care Unit, Pediatric Hospital of Sinaloa, Culiacan, Mexico.
Hector Melesio Cuen-DiazFCA, Autonomous University of Sinaloa, Culiacan, Mexico.
Ricardo Zatarain-LopezSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Adrian Canizalez-RomanSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Pediatric Hospital of Sinaloa · MXAutonomous University of Sinaloa · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multisystem inflammatory syndrome in children (MIS-C), is a severe complication of coronavirus disease 2019 (COVID-19), characterized by persistent fever, systemic inflammatory response, and organ failure. MIS-C with a history of COVID-19 may share clinical features with other well-defined syndromes such as macrophage activation syndrome, Kawasaki disease, hemophagocytic syndrome and toxic shock syndrome. Case 1: An 11-year-old male with a history of hypothyroidism and precocious puberty with positive antibody test for COVID-19 was admitted for fever, poor general condition, severe respiratory distress, refractory shock, and multiple organ failure. His laboratory examination showed elevated inflammatory parameters, and bone marrow aspirate showed hemophagocytosis. Case 2: A 13-year-old male with a history of attention deficit hyperactivity disorder and cognitive delay presented clinical manifestations of Kawasaki disease, fever, conjunctival congestion, exanthema, and hyperemia in oral mucosa, tongue, and genitals, with refractory shock and multiple organ failure. Reverse transcriptase polymerase chain reaction (RT-PCR) and antibodies for COVID-19 were negative, inflammation parameters were elevated, and bone marrow aspirate showed hemophagocytosis. Patients required intensive care with invasive mechanical ventilation, vasopressor support, intravenous gamma globulin, systemic corticosteroids, low molecular weight heparin, antibiotics, and monoclonal antibodies and, patient 2 required renal replacement therapy. Conclusions: Multisystemic inflammatory syndrome in children can have atypical manifestations, and identifying them early is very important for the timely treatment and prognosis of patients.

Indexed as

COVID-19Kawasaki disease (KD)macrophage activation syndrome (MAS)multisystemic inflammatory syndrome in children (MIS-C)SARS-CoV-2

Identifiers

PMID37138560
PMCPMC10149839
OpenAlexW4366224259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.